Ksizal film-coated tablets 5 mg, # 14
Category
Allergy
Scope of the drug
Leather
,
Dermatology
Release form
Tablet
Manufacturer country
Switzerland
Package quantity, pcs
14
Ksizal tab.
p / o captivity.
5mg No. 14
Name ENG
XYZAL
Clinical and pharmacological group
Blocker of histamine H1 receptors.
Antiallergic drug
ATX code
Levocetirizine
Dosage
5mg
Structure
1 tablet contains 5 mg levocetirizine dihydrochloride.
Indications
Symptomatic therapy of allergic diseases and conditions: - year-round (persistent) and seasonal (intermittent) allergic rhinitis and allergic conjunctivitis (itching, sneezing, rhinorrhea, lacrimation, conjunctival hyperemia, nasal congestion)
- hay fever (hay fever)
- urticaria (including chronic idiopathic urticaria)
- Quincke's edema
- other allergic dermatoses, accompanied by itching and rashes.
INN / Active ingredient
Levocetirizine
Storage conditions and periods
In a dry place, at a temperature not exceeding 25 degrees.
Expiration date: 4 years
Contraindications
Terminal stage of renal failure (CC less than 10 ml / min)
- children under 6 years of age (for tablets)
- children under 2 years of age (for oral drops)
- pregnancy
- hypersensitivity to the components of the drug, especially in patients with galactosemia or severe lactose intolerance (for tablets)
- hypersensitivity to levocetirizine or piperazine derivatives.
The drug should be used with caution in chronic renal failure (dosage adjustment is required), in elderly patients (with age-related decrease in glomerular filtration).
Specifications
Category
Allergy
Scope of the drug
Leather
,
Dermatology
Release form
Tablet
Manufacturer country
Switzerland
Package quantity, pcs
14
Scope of application
Allergology
Minimum age from
6 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
UCB Farchim
The amount of the dosage form in the primary package
7 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
R06AE09 Levocetirizine
Dosage form
Film-coated tablets
Dosage (volume) of the substance in the preparation
levocetirizine dihydrochloride 5 mg
Expiration date in days
1461
Package weight, g
twenty
Mode of application
:
It is taken orally with food or on an empty stomach, with a small amount of water without chewing.
Adults and children over 6 years old: daily dose - 5 mg (1 tablet).
Elderly patients (subject to normal renal function) dose reduction is not required.
For patients with chronic renal failure, the dose is reduced by half (1 tablet every other day) with CC from 30 to 49 ml / min and 3 times (1 tablet every 3 days) with CC from 10 to 29 ml / min.
Patients with hepatic insufficiency do not need to correct the dosage regimen.
< br> The duration of admission depends on the disease.
For the treatment of pollinosis, it is prescribed on average for 1-6 weeks.
In chronic diseases (perennial rhinitis, atonic dermatitis), the duration of treatment may increase to 18 months.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker